Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.Dietrich C. Gulba, P. R. Lichtlen, W. Rafflenbeul et al.|Circulation|1991Cited by 173
Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy)P. R. Lichtlen, Jaap W. Deckers, Paul G. Hugenholtz et al.|Cardiovascular Drugs and Therapy|1990Cited by 93